Literature DB >> 3111513

Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.

S M Rogers, D J Back, P J Stevenson, S F Grimmer, M L Orme.   

Abstract

The effect of a single dose of paracetamol (1 g) on plasma concentrations of the oral contraceptive steroids ethinyloestradiol (EE2) and levonorgestrel (LNG) has been studied in six healthy female volunteers. The area under the plasma concentration-time curve (AUC0-24) of EE2 was significantly increased following paracetamol administration by 22% (control 2221 +/- 291; following paracetamol, 2702 +/- 452 pg ml-1 h; mean +/- s.d.; P less than or equal to 0.05). The greatest effect was evident in the time period 0-3 h. There was a significant decrease in the AUC of EE2-sulphate after paracetamol (7736 +/- 3791 pg ml-1 h) compared with control (13161 +/- 4535 pg ml-1 h; P less than or equal to 0.05). Plasma concentrations of LNG were unaltered by concurrent paracetamol administration. We conclude that the administration of a single 1 g dose of paracetamol causes an increase in plasma concentrations of EE2 as a result of a reduction in the sulphation of the steroid. This interaction may be of clinical significance in women on oral contraceptive steroids who regularly take paracetamol.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Demographic Factors; Drug Interactions; Drugs; Endocrine System; Ethinyl Estradiol; Family Planning; Human Volunteers; Levonorgestrel; Metabolic Effects; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Population; Population Dynamics; Prostaglandin Antagonists; Prostaglandins; Research Methodology; Steroid Metabolic Effects; Time Factors; Treatment

Mesh:

Substances:

Year:  1987        PMID: 3111513      PMCID: PMC1386167          DOI: 10.1111/j.1365-2125.1987.tb03107.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.

Authors:  G Levy; H Yamada
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

2.  Interaction of ethinyloestradiol with ascorbic acid in man.

Authors:  D J Back; A M Breckenridge; M MacIver; M L Orme; H Purba; P H Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

Review 3.  Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion.

Authors:  G Levy; R E Galinsky; J H Lin
Journal:  Drug Metab Rev       Date:  1982       Impact factor: 4.518

4.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

Authors:  R E Galinsky; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

5.  Pharmacokinetics of salicylamide elimination in man.

Authors:  G Levy; T Matsuzawa
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

6.  Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid.

Authors:  J B Houston; G Levy
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

7.  The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans.

Authors:  D J Back; A M Breckenridge; M MacIver; M Orme; H S Purba; P H Rowe; I Taylor
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

Review 8.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

9.  Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers.

Authors:  S M Rogers; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

10.  An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe; M J Watts
Journal:  Contraception       Date:  1979-09       Impact factor: 3.375

View more
  11 in total

Review 1.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

Review 3.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

4.  Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.

Authors:  Anne Caroline S Barbosa; Ye Feng; Chaohui Yu; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-03-18       Impact factor: 4.481

Review 5.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 6.  Oral contraceptives. Are drug interactions of clinical significance?

Authors:  G M Shenfield
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

7.  The allosteric binding sites of sulfotransferase 1A1.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2014-12-22       Impact factor: 3.922

8.  Influence of vitamin C on the absorption and first pass metabolism of propranolol.

Authors:  J P Gonzalez; A Valdivieso; R Calvo; J M Rodríguez-Sasiaín; R Jimenez; C Aguirre; P du Souich
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 9.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

10.  Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers.

Authors:  S M Rogers; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.